Insignis Therapeutics Inc. — Form D
Insignis Therapeutics Inc. of NORTH HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2026-08-05. The offering totals $8.5M, of which $6.0M was reported sold. Industry: Other.
Offering
- Filed: 2026-08-05
- Form: D
- Accession: 0001493152-26-036132
- Industry: Other
- Exemptions: 06b
- Total offering: $8.5M
- Amount sold: $6.0M
- Remaining: $2.5M
- Minimum investment: $1
- Investors: 4
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-593201
Issuer
- Name: Insignis Therapeutics Inc.
- CIK: 0001981826
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 410 SACKETT POINT ROAD BUILDING 20, NORTH HAVEN, CT, 06473
- Phone: 203-570-8879
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Mingbao Zhang | Related Person | North Haven, CT |
| Mingbao Zhang | Executive Officer | North Haven, CT |
Other filings by this issuer (1)
More